Literature DB >> 21422300

κ-Opioid receptor inhibition of calcium oscillations in spinal cord neurons.

Lakshmi Kelamangalath1, Shashank M Dravid, Joju George, Jane V Aldrich, Thomas F Murray.   

Abstract

Mouse embryonic spinal cord neurons in culture exhibit spontaneous calcium oscillations from day in vitro (DIV) 6 through DIV 10. Such spontaneous activity in developing spinal cord contributes to maturation of synapses and development of pattern-generating circuits. Here we demonstrate that these calcium oscillations are regulated by κ opioid receptors (KORs). The κ opioid agonist dynorphin (Dyn)-A (1-13) suppressed calcium oscillations in a concentration-dependent manner, and both the nonselective opioid antagonist naloxone and the κ-selective blocker norbinaltorphimine eliminated this effect. The KOR-selective agonist (+)-(5α,7α,8β)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-benzeneacetamide (U69593) mimicked the effect of Dyn-A (1-13) on calcium oscillations. A κ-specific peptide antagonist, zyklophin, was also able to prevent the suppression of calcium oscillations caused by Dyn-A (1-13). These spontaneous calcium oscillations were blocked by 1 μM tetrodotoxin, indicating that they are action potential-dependent. Although the L-type voltage-gated calcium channel blocker nifedipine did not suppress calcium oscillations, the N-type calcium channel blocker ω-conotoxin inhibited this spontaneous response. Blockers of ionotropic glutamate receptors, 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline and dizocilpine maleate (MK-801), also suppressed calcium oscillations, revealing a dependence on glutamate-mediated signaling. Finally, we have demonstrated expression of KORs in glutamatergic spinal neurons and localization in a presynaptic compartment, consistent with previous reports of KOR-mediated inhibition of glutamate release. The KOR-mediated inhibition of spontaneous calcium oscillations may therefore be a consequence of presynaptic inhibition of glutamate release.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422300      PMCID: PMC3102554          DOI: 10.1124/mol.111.071456

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  The expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in neurochemically defined axonal populations in the rat spinal cord with emphasis on the dorsal horn.

Authors:  A J Todd; D I Hughes; E Polgár; G G Nagy; M Mackie; O P Ottersen; D J Maxwell
Journal:  Eur J Neurosci       Date:  2003-01       Impact factor: 3.386

2.  Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones.

Authors:  R L Macdonald; M A Werz
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

3.  Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory.

Authors:  Andrew C Charles; Natalya Mostovskaya; Kathleen Asas; Christopher J Evans; Megan L Dankovich; Tim G Hales
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

4.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor.

Authors:  C Chavkin; I F James; A Goldstein
Journal:  Science       Date:  1982-01-22       Impact factor: 47.728

5.  Specific receptor for the opioid peptide dynorphin: structure--activity relationships.

Authors:  C Chavkin; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

6.  Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons.

Authors:  R Przewlocki; K L Parsons; D D Sweeney; C Trotter; J G Netzeband; G R Siggins; D L Gruol
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

7.  Characterization of the circuits that generate spontaneous episodes of activity in the early embryonic mouse spinal cord.

Authors:  M Gartz Hanson; Lynn T Landmesser
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 8.  Mechanisms underlying spontaneous patterned activity in developing neural circuits.

Authors:  Aaron G Blankenship; Marla B Feller
Journal:  Nat Rev Neurosci       Date:  2009-12-02       Impact factor: 34.870

9.  Spontaneous synchronized calcium oscillations in neocortical neurons in the presence of physiological [Mg(2+)]: involvement of AMPA/kainate and metabotropic glutamate receptors.

Authors:  Shashank M Dravid; Thomas F Murray
Journal:  Brain Res       Date:  2004-04-23       Impact factor: 3.252

10.  Amino acid receptor-mediated transmission at primary afferent synapses in rat spinal cord.

Authors:  T M Jessell; K Yoshioka; C E Jahr
Journal:  J Exp Biol       Date:  1986-09       Impact factor: 3.312

View more
  6 in total

1.  A non-opioid pathway for dynorphin-caused spinal cord injury in rats.

Authors:  Yu Chen; Liangbi Xiang; Jun Liu; Dapeng Zhou; Hailong Yu; Qi Wang; Wenfeng Han; Mingming Guo
Journal:  Neural Regen Res       Date:  2012-04-15       Impact factor: 5.135

2.  Bulleyaconitine A Inhibits Visceral Nociception and Spinal Synaptic Plasticity through Stimulation of Microglial Release of Dynorphin A.

Authors:  Sheng-Nan Huang; Jinbao Wei; Lan-Ting Huang; Pei-Jun Ju; Jinghong Chen; Yong-Xiang Wang
Journal:  Neural Plast       Date:  2020-05-23       Impact factor: 3.599

3.  BmK NSPK, a Potent Potassium Channel Inhibitor from Scorpion Buthus martensii Karsch, Promotes Neurite Outgrowth via NGF/TrkA Signaling Pathway.

Authors:  Fang Zhao; Xiaohan Zou; Shaoheng Li; Jing He; Chuchu Xi; Qinglian Tang; Yujing Wang; Zhengyu Cao
Journal:  Toxins (Basel)       Date:  2021-01-05       Impact factor: 4.546

4.  The dopamine D1-D2DR complex in the rat spinal cord promotes neuropathic pain by increasing neuronal excitability after chronic constriction injury.

Authors:  Yi-Ni Bao; Wen-Ling Dai; Ji-Fa Fan; Bin Ma; Shan-Shan Li; Wan-Li Zhao; Bo-Yang Yu; Ji-Hua Liu
Journal:  Exp Mol Med       Date:  2021-02-09       Impact factor: 8.718

5.  Blockade of spinal dopamine D1/D2 receptor suppresses activation of NMDA receptor through Gαq and Src kinase to attenuate chronic bone cancer pain.

Authors:  Wen-Ling Dai; Yi-Ni Bao; Ji-Fa Fan; Bin Ma; Shan-Shan Li; Wan-Li Zhao; Bo-Yang Yu; Ji-Hua Liu
Journal:  J Adv Res       Date:  2020-08-13       Impact factor: 10.479

6.  Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.

Authors:  Yuanzi Zhao; Anand A Joshi; Jane V Aldrich; Thomas F Murray
Journal:  Biomed Pharmacother       Date:  2021-09-15       Impact factor: 6.529

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.